The efficacy and safety of lurasidone in bipolar I depression with and without rapid cycling: A pooled post-hoc analysis of two randomized, placebo-controlled trials-Reference-Cited by-同舟云学术

The efficacy and safety of lurasidone in bipolar I depression with and without rapid cycling: A pooled post-hoc analysis of two randomized, placebo-controlled trials

Published:2023-09 Issue: Volume:337 Page:150-158
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Kato Masaki,Masuda Takahiro,Sano Fumiya,Kato Tadafumi

Funder

Sumitomo Pharma Co Ltd

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference45 articles.

1. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression;Bech;Psychopharmacology (Berlin),2002

2. A randomized open comparison of long-acting injectable risperidone and treatment as usual for prevention of relapse, rehospitalization, and urgent care referral in community-treated patients with rapid cycling bipolar disorder;Bobo;Clin. Neuropharmacol.,2011

3. Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder;Calabrese;Eur. Neuropsychopharmacol.,2017

4. Rapid cycling in bipolar disorder: a systematic review;Carvalho;J. Clin. Psychiatry,2014

5. The long-term course of rapid-cycling bipolar disorder;Coryell;Arch. Gen. Psychiatry,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rash caused by lurasidone in old chinese patient with bipolar disorder: case-based review;BMC Psychiatry;2024-07-08